Potential targets of TMEM176A in the growth of glioblastoma cells

References

• SturmDBenderSJonesDTPaediatric and adult glioblastoma: multiform (epi)genomic culprits emergeNat Rev Cancer20141429210724457416
   PubMed Web of Science ®Google Scholar
• GerberNKGoenkaATurcanSTranscriptional diversity of long-term glioblastoma survivorsNeuro Oncol20141691186119524662514
   PubMed Web of Science ®Google Scholar
• SunGShiLYanSMiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cellsBiomed Res Int2014201468782624995320
   PubMed Web of Science ®Google Scholar
• XiaBYangSLiuTLouGmiR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6Mol Cancer2015145725889927
   PubMed Web of Science ®Google Scholar
• WangYZhangYHermanJGLinghuEGuoMEpigenetic silencing of TMEM176A promotes esophageal squamous cell cancer developmentOncotarget2017841700357004829050260
   PubMedGoogle Scholar
• CuajungcoMPPodevinWValluriVKBuiQNguyenVHTaylorKAbnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathologyActa Histochem2012114770571222244448
   PubMed Web of Science ®Google Scholar
• SunWQiuGZouYKnockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cellsInt J Clin Exp Pathol2015810126571266726722455
   PubMed Web of Science ®Google Scholar
• ZhangQChenXZhangXZhanJChenJKnockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cellsBiosci Rep2016361e0029826896463
   PubMed Web of Science ®Google Scholar
• QiuGSunWZouYRNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cellsTumour Biol201536108231823826002575
   PubMedGoogle Scholar
• TanakaTKubotaMShinoharaKYasudaKKatoJYIn vivo Analysis of the Cyclin D1 Promoter during Early Embryogenesis in XenopusCell Struct Funct20032816517712951437
   PubMed Web of Science ®Google Scholar
• LiangSMuKWangYCyclinD1, a prominent prognostic marker for endometrial diseasesDiagn Pathol2013813823947899
   PubMed Web of Science ®Google Scholar
• AhlinCLundgrenCEmbretsén-VarroEJirströmKBlomqvistCFjällskogMHigh expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancersBreast Cancer Res Treat2017164366767828528450
   PubMed Web of Science ®Google Scholar
• OrCRChangYLinWCObatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma CellsInt J Mol Sci2016181E4428035994
   PubMed Web of Science ®Google Scholar
• SunGSimaGWuCDecreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and AktPLoS One2018131e019051529351283
   PubMed Web of Science ®Google Scholar
• DaiMAl-OdainiAAFils-AiméNCyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasionBreast Cancer Res2013153R4923786849
   PubMed Web of Science ®Google Scholar
• JunGJZhongGGMingZSmiR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/ P21(Cip1/Waf1) pathwayOncol Lett2015962743274926137139
   PubMed Web of Science ®Google Scholar
• HukkelhovenELiuYYehNCiznadijaDBlainSWKoffATyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural gliomaJ Biol Chem201228746385233853023007395
   PubMed Web of Science ®Google Scholar
• LeeJSXiaoJPatelPA novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1Neuro Oncol201416219120324305710
   PubMed Web of Science ®Google Scholar
• Carrillo GarcíaCRiedtTLiJDottenMBrossartPJanzenVSimultaneous deletion of p21Cip1/Waf1 and caspase-3 accelerates proliferation and partially rescues the differentiation defects of caspase-3 deficient hematopoietic stem cellsPLoS One2014910e10926625286245
   PubMed Web of Science ®Google Scholar
• HuQPengJLiuWElevated cleaved caspase-3 is associated with shortened overall survival in several cancer typesInt J Clin Exp Pathol2014785057507025197379
   PubMed Web of Science ®Google Scholar
• PuXStorrSJZhangYCaspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survivalApoptosis201722335736827798717
   PubMed Web of Science ®Google Scholar
• YangXZhongDNQinHCaspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 casesOncotarget2018998629864129492222
   PubMedGoogle Scholar
• ShangNBankTDingXCaspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activationCell Death Dis20189555829752472
   PubMed Web of Science ®Google Scholar
• SteghAHKesariSMahoneyJEBcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastomaProc Natl Acad Sci U S A200810531107031070818669646
   PubMed Web of Science ®Google Scholar
• CuiJPlaczekWJPost-Transcriptional Regulation of Anti-Apoptotic BCL2 Family MembersInt J Mol Sci2018191E30829361709
   PubMed Web of Science ®Google Scholar
• ViantCGuiaSHennessyRJCell cycle progression dictates the requirement for BCL2 in natural killer cell survivalJ Exp Med2017214249151028057804
   PubMed Web of Science ®Google Scholar
• YangTQLuXJWuTFMicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathwayCancer Sci2014105326527124418124
   PubMed Web of Science ®Google Scholar
• HanJChenQMiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cellsInt J Clin Exp Pathol2015810126981270726722459
   PubMed Web of Science ®Google Scholar
• PapageorgiouSGKontosCKPappaVThe novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarkerOncologist20111691280129121737576
   PubMed Web of Science ®Google Scholar
• PandeyVBhaskaraVKBabuPPImplications of mitogen-activated protein kinase signaling in gliomaJ Neurosci Res201694211412726509338
   PubMed Web of Science ®Google Scholar
• MoonDOParkSYHeoMSKey regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and AktInt Immunopharmacol20066121796180717052670
   PubMed Web of Science ®Google Scholar
• KolbRHGreerPMCaoPTCowanKHYanYERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activationPLoS One2012711e5028123166842
   PubMed Web of Science ®Google Scholar
• JinLCaoYZhangTEffects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cellsInt J Mol Med20184131339134829286066
   PubMed Web of Science ®Google Scholar
• ChenDZuoDLuanCGlioma cell proliferation controlled by ERK activity-dependent surface expression of PDGFRAPLoS One201491e8728124489888
   PubMed Web of Science ®Google Scholar
• CeramiEDemirESchultzNTaylorBSSanderCAutomated network analysis identifies core pathways in glioblastomaPLoS One201052e891820169195
   PubMed Web of Science ®Google Scholar
• WangXYuZZhouQTissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathwayOncotarget2016767066707926771235
   PubMedGoogle Scholar
• DoerksTCopleyRRSchultzJPontingCPBorkPPhosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformationGenome Res2002121475611779830
   PubMed Web of Science ®Google Scholar
• HuiWYuntaoLLunLMicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1PLoS One201381e5493223383003
   PubMed Web of Science ®Google Scholar
• VelpulaKKDasariVRTsungAJRegulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1PLoS One201163e1801721455311
   PubMed Web of Science ®Google Scholar
• WangHYYangSLLiangHFLiCHChLHBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathwaysInt J Mol Sci20141533507351824577313
   PubMed Web of Science ®Google Scholar